The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 29, 2022

Filed:

Feb. 25, 2020
Applicants:

Mackay Memorial Hospital, Taipei, TW;

Goldred Nanobiotech Co., Ltd., Taoyuan, TW;

Inventors:

Hsueh-Hsiao Wang, New Taipei, TW;

Hung-I Yeh, Taipei, TW;

Hong-Shong Chang, Taoyuan, TW;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/242 (2019.01); A61K 9/51 (2006.01); A61P 29/00 (2006.01); A61K 9/00 (2006.01); A61K 31/5415 (2006.01); A61P 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/20 (2006.01);
U.S. Cl.
CPC ...
A61K 33/242 (2019.01); A61K 9/5123 (2013.01); A61P 29/00 (2018.01);
Abstract

Disclosed herein is a method for treating an inflammatory disease in a subject, including administering to the subject a therapeutically effective amount of a dihydrolipoic acid (DHLA) coated gold nanocluster about 0.1 to 20 nm in diameter. Also disclosed is a method for reducing the expression of a pro-inflammatory molecule in a cultured cell, including contacting the cultured cell with the said DHLA coated gold nanocluster. Still disclosed is a pharmaceutical composition that includes the present DHLA coated gold nanocluster. The pharmaceutical composition is useful for treating the inflammatory disease in the subject.


Find Patent Forward Citations

Loading…